Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction

NCT01088191 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Cruciate Ligament Injury
Osteoarthritis

Interventions

BIOLOGICAL: MSB-CAR001 Combined With Hyaluronan
DRUG: Hyaluronan

Sponsor

Mesoblast, Ltd.